Breast Cancer

Why breast cancer patients may gain weight during treatment and how to manage it.

A resource listing of men’s groups dedicated to helping other men cope with their spouse’s cancer while contributing to cancer research.

An approval in breast cancer, positive clinical trial results in liver cancer, while a prostate cancer drug disappoints.

This article discusses genetic test kits and the types of cancer they test for.

Updates from the American Society of Hematology Meeting and the San Antonio Breast Cancer Symposium.

New approvals for colorectal, lung, breast, head & neck cancer and lymphoma.

Therapies improve for asbestos-caused cancer.

Status of noninvasive breast cancer gets some clarity.

Researchers designed the Van Nuys Prognostic Index to aid in treatment decisions for women diagnosed with ductal carcinoma in situ, DCIS.

Asbestos litigation has become the most costly mass tort in U.S. legal history.

Dr. Aman Buzdar discusses the latest breast cancer treatment strategies with aromatase inhibitors.

Zora Brown's longtime enemy caused her to remake her life to educate African-American women about breast cancer.

The individual & family decisions behind testing for genetic cancer risk.

Learning about one's genetic status may open a Pandora's box of personal and familial issues.

Chemoprevention options exist for individuals with high risk of breast, prostate, or colorectal cancers.

This article discusses premature menopause as a result of cancer treatments.

Survivors guided through territory of long-term and late effects.

Cancer survivors deal with fear.

How to help children deal with the fear of their parents’ cancer.

The guilt of possibly passing on the risk of breast cancer drives a survivor to undergo genetic testing.

Finding comfort in life's new territory.

In addition to treatment-related risks, some survivors discover they have a genetic syndrome that may lead to a second cancer.

Updates from the 2006 annual meeting of the American Society of Clinical Oncology.

Young adult survivor Molly McMaster turns her experience into a national tour and non-profit group dedicated to raising awareness on colon cancer.

Eight years after its approval, Herceptin emerges as the best weapon against HER2-positive breast cancer.

A closer look at bioidentical hormones and why one pharmaceutical company wants the FDA to keep a closer eye on them.

From mastectomy to reconstruction and beyond.

The challenges of breast cancer in women under 40.

The progress made in genetic testing for breast cancer.

Women with a history of breast cancer should not take HRT.